Langar Holdings Company Profile

Background

Mission and Vision

Langar Holdings is dedicated to enhancing public access to HealthTech information and investments through a trusted community of experts and proprietary data analytics. The company is committed to working with a diverse community of experts, believing in representation on all fronts. Their team is inclusive of different ages, races, genders, and professional backgrounds, including healthcare, technology, finance, marketing, pharmaceuticals, and data science. Each member's varying levels of experience bring a diversity of thought, and the culture encourages everyone to voice their perspectives. Langar Holdings stays committed to expanding and further diversifying their team as they continue to grow.

Primary Area of Focus and Industry Significance

Langar Holdings operates within the HealthTech sector, focusing on leveraging technology to create efficiency in healthcare by addressing key pain points of patients, providers, payors, and hospitals. The company utilizes a data-driven, proprietary process to objectively perform due diligence on HealthTech companies, aiming to provide access to investing in high-growth HealthTech companies.

Key Strategic Focus

Core Objectives

Langar Holdings aims to increase public access to HealthTech information and investments by utilizing a data-driven, proprietary process to objectively perform due diligence on HealthTech companies. This approach enables them to select high-growth companies for long-term investments.

Specific Areas of Specialization

The company specializes in identifying and investing in HealthTech companies that address key inefficiencies in the healthcare system, targeting sectors such as Access to Care, Biopharma, Clinical Trials, Decision Support, Hospital Operations, Insurance, and Treatment Devices.

Key Technologies Utilized

Langar Holdings employs proprietary data analytics and a structured due diligence process to evaluate and select HealthTech companies. Their approach includes a top-down review combining policy, industry, and innovation experience to actively mitigate risk, and a bottom-up research methodology that selects fundamentally strong companies addressing pain points in healthcare.

Primary Markets or Conditions Targeted

The company targets the global HealthTech market, focusing on companies that develop technology to create efficiency in healthcare by solving key pain points of patients, providers, payors, and hospitals.

Financials and Funding

Funding History and Total Funds Raised

Specific details regarding Langar Holdings' total funds raised are not publicly disclosed.

Recent Funding Rounds and Notable Investors

Information about recent funding rounds and notable investors is not publicly available.

Intended Utilization of Capital

While specific details on the utilization of capital are not publicly disclosed, it is likely that funds are allocated towards expanding their portfolio of HealthTech investments, enhancing their proprietary data analytics capabilities, and supporting the growth and diversification of their team.

Pipeline Development

Key Pipeline Candidates and Stages of Development

Langar Holdings focuses on investing in high-growth HealthTech companies across various sectors, including Access to Care, Biopharma, Clinical Trials, Decision Support, Hospital Operations, Insurance, and Treatment Devices. The company employs a proprietary process to evaluate and select companies in these sectors, aiming to provide access to investing in high-growth HealthTech companies.

Target Conditions and Relevant Timelines

Specific details regarding target conditions and timelines for anticipated milestones are not publicly disclosed.

Technological Platform and Innovation

Proprietary Technologies

Langar Holdings utilizes a proprietary data-driven process to perform due diligence on HealthTech companies, enabling them to objectively evaluate and select high-growth companies for investment.

Significant Scientific Methods

The company employs a top-down review combining policy, industry, and innovation experience to actively mitigate risk, and a bottom-up research methodology that selects fundamentally strong companies addressing pain points in healthcare.

Leadership Team

Key Executive Profiles

• Dhruv K. Vig, PhD: Chief Executive Officer & Founder. Dr. Vig co-founded Langar Holdings and serves as the CEO. Prior to founding Langar Holdings, he built the global healthcare research division at Silicon Valley Bank, was a founder at the HealthTech startup Decoded Health, and was part of SRI International’s venture team. Dr. Vig holds an A.B. from Kenyon College in molecular biology and mathematics, a Ph.D. from the University of Arizona in computational molecular and cellular biology, and completed a post-doctoral fellowship at Johns Hopkins University in cellular biophysics.

• Sanjana Vig, MD, MBA: Chief Marketing Officer & Founder. Dr. Vig co-founded Langar Holdings and serves as the CMO. Prior to founding Langar Holdings, she founded The Female Professional, a website geared toward empowering women in life and their careers. She is currently a board-certified anesthesiologist at the University of California, San Diego. Dr. Vig holds a B.A., M.D., and M.B.A. from St. Louis University in biology, completed her residency at Mt. Sinai Hospital (NYC), and her fellowship at Stanford University in Perioperative Management.

Key Contributions or Roles within the Company

Dr. Dhruv K. Vig serves as the CEO, leading the strategic direction and operations of Langar Holdings. Dr. Sanjana Vig serves as the CMO, overseeing marketing strategies and initiatives.

Competitor Profile

Market Insights and Dynamics

The HealthTech sector is experiencing significant growth, driven by the increasing need for technological solutions to address inefficiencies in healthcare. The global healthcare market is projected to reach $6.8 trillion by 2030, with a substantial portion attributed to wasteful spending that HealthTech companies aim to address.

Competitor Analysis

Langar Holdings operates in a competitive landscape with several key players:

• HealthTech Investment Firms: Companies like Health Catalyst Capital, Health Enterprise Partners, and Echo Health Ventures focus on investing in HealthTech startups, targeting similar inefficiencies in the healthcare system.

• HealthTech ETFs: Exchange-traded funds such as the Global X Health & Wellness Thematic ETF (BFIT) and the ARK Genomic Revolution ETF (ARKG) provide investors with exposure to a diversified portfolio of HealthTech companies.

Strategic Collaborations and Partnerships

Specific details regarding strategic collaborations and partnerships are not publicly disclosed.

Operational Insights

Langar Holdings differentiates itself through its proprietary data-driven process for evaluating and selecting HealthTech companies, aiming to provide access to investing in high-growth HealthTech companies.

Strategic Opportunities and Future Directions

Langar Holdings is well-positioned to capitalize on the growing demand for HealthTech solutions by expanding its portfolio of investments, enhancing its proprietary data analytics capabilities, and continuing to diversify its team to bring a variety of perspectives and expertise to the company.